Simon Webster looks at the role of intellectual property (IP) management in protecting pharmaceutical company products.
Haydn Evans
Advertisement
Haydn Evans is Vice President, IP Outsourcing, Eurpe, at CPA Global (UK).
Articles by Haydn Evans
Advertisement
Latest Updated Articles
The Need for Intelligent IP managementPublished: February 10th 2017 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
uniQure and FDA Clash Over Regulatory Decision for Huntington’s Disease Therapy: Report
2
Advancing Full-Spectrum Cannabis Through FDA
3
From Approval to Access: 4 Steps to Rethinking Market Access Strategy in Specialty Pharma
4
Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options
5